RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Raw

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents1134842305366498095358131,4681,6182,1942,8863,1062,7302,488
Marketable securities13743781582522365035971,3421,5971,3932,8094,6368,1156,524
Accounts receivable, net14285937877391,1521,3431,5391,7242,1003,1126,0375,3295,6676,212
Inventories---701292393997261,1511,4161,9171,9512,4022,5813,087
Prepaid expenses and other current assets-23579671164131225243387161332411387349
Total current assets3586531,2061,7972,1672,9153,1804,3356,4487,6899,77914,01515,88419,47918,661
Marketable securities3702762713904606328641,4861,7553,2573,1366,8386,5925,3978,900
Property, plant, and equipment, net---------2,8903,2223,4823,7634,1464,600
Intangible assets, net------------9161,0391,149
Deferred tax assets--------8298248598771,7242,5753,314
Other noncurrent assets7192353620781271451682233364441,136
Total assets1,0891,3242,0802,9513,8725,6096,9738,76411,73514,80517,16325,43529,21533,08037,759
Accounts payable--------218418476564589607790
Accrued Liabilities and Other Liabilities--------7721,0871,5222,2072,0742,3582,527
Deferred revenue--------453592-442478459628
Total current liabilities1091481642996558111,2411,1351,4432,0972,6973,9333,1413,4233,944
Long-term debt----------1,9791,9801,9811,9831,984
Finance lease liabilities---------714717-720720720
Deferred revenue--------464619-7370127186
Other noncurrent liabilities7671141116100152362286-6806388541,571
Total liabilities5628388359991,3301,9542,5242,6202,9773,7166,1386,6666,5517,1078,406
Preferred Stock, Value, Issued0--------------
Class A Stock00000000-------
Common Stock--0000000000000
Common stock00-------------
Additional paid-in capital1,5761,7551,7642,0462,4043,1003,0303,5133,9124,4296,7168,0889,94911,35412,856
Retained earnings-1,046-1,267-517-932558531,7482,9475,2547,38010,89318,96823,30727,26031,673
Accumulated other comprehensive loss-2-2-1-1529-131-122129-26-239-81-8
Treasury Stock, at cost; 28.2 shares in 2024 and 25.5 shares in 2023------------10,35312,56015,167
Class A Stock0---0000-------
Common Stock----0000000----
Total stockholders' equity5284861,2451,9522,5423,6554,4496,1448,75711,09011,02518,76922,66425,97329,354
Total liabilities and stockholders' equity1,0891,3242,0802,9513,8725,6096,9738,76411,73514,80517,16325,43529,21533,08037,759